Keenova Therapeutics plc: 10% owner GoldenTree bought 137,000 shares

What happened The filing reports that GoldenTree Asset Management LP, a 10% owner, purchased 137,000 ordinary shares in an open-market purchase at $90.00 per share on Oct 14, 2026, for $12,330,000.

Key details

• Transaction date and price: Oct 14, 2026; purchase at $90.00 per share.
• Shares acquired and value: 137,000 shares for $12,330,000.
• Shares owned after the transaction: the filing states the securities reported include 8,526,212 ordinary shares held directly by certain funds and separate accounts managed by the advisor and 53,615 ordinary shares held directly by Steven A. Tananbaum.
• Footnotes: the Form 4 is filed on behalf of GoldenTree Asset Management LP (the advisor), GoldenTree Asset Management LLC (the general partner) and Steven A. Tananbaum; the advisor manages the funds that hold the reported shares; the advisor, the general partner and Mr. Tananbaum disclaim beneficial ownership of the shares held by the funds.
• Filing date: filed Oct 16, 2026 (reporting period Oct 14, 2026).

Why it may matter

• The transaction was by a 10% owner, i.e., a large holder rather than an executive.
  A filing does not show why the insider traded or why the company acted.